Geraldine O’Keeffe joined EQT in 2008 and is a Partner in the EQT Private Capital team, dedicated to the Healthcare sector. Geraldine joined EQT through its combination with LSP, where she worked from 2008 until 2022, when LSP was renamed EQT Life Sciences.
Prior to joining LSP, Geraldine worked as a Senior Equity Research analyst at Fortis Bank in Amsterdam, The Netherlands. Prior to Fortis, Geraldine was Head of Infectious disease at medical diagnostic company Biotrin (now part of Diasorin) in Dublin, Ireland.
Geraldine holds an BSc Hons in Microbiology and Biochemistry, University College Cork, an MSc in Biotechnology from University College Galway, and a Graduate Diploma in Business Studies from Dublin School of Business.